Postoperative Nausea and Vomiting
📧 Sign up to get email alerts when something new happens for Postoperative Nausea and Vomiting.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-13Clinical Trial Update: Postoperative Vomiting in Children: Comparison Tri - Versus bi -Prophylaxis [NA]
This clinical trial compared triple- versus bi-prophylaxis for preventing postoperative vomiting in children; the study status is completed.
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Effect of BIS-Guided Anesthesia on Postoperative Nausea and Vomiting in Pediatric Patients [NA]
Clinical trial evaluating BIS-guided anesthesia to reduce postoperative nausea and vomiting in pediatric patients has completed.
-
FDA approval · 2026-02-09FDA Approved: SCOPOLAMINE TRANSDERMAL SYSTEM — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
The FDA approved a supplemental application for Scopolamine Transdermal System from Padagis Israel Pharmaceuticals Ltd.
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Association Between Preoperative Metformin Exposure and Postoperative Nausea and Vomiting in Patients Undergoing General Anesthesia
This clinical trial examines whether preoperative exposure to metformin influences the incidence of postoperative nausea and vomiting in pat…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Propofol Infusion and PONV in Cardiac Surgery
A ClinicalTrials.gov entry reports a recruiting study evaluating whether propofol infusion can reduce postoperative nausea and vomiting in p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Intravenous Nalbuphine for Prevention of Intrathecal Morphine-induced Nausea and Vomiting in Patients Undergoing Cesarean Section: A Double-blind, Randomized Controlled Trial. [NA]
A completed double-blind randomized trial evaluated intravenous nalbuphine for prevention of intrathecal morphine-induced nausea and vomitin…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Granisetron Combined With Dexamethasone or Metoclopramide for PONV Prevention After Laparoscopic Cholecystectomy [Phase 4]
This phase 4 study investigates granisetron combined with dexamethasone or metoclopramide for preventing postoperative nausea and vomiting a…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Intrathecal Dexamethasone and Atropine on Morphine Induced Post-operative Nausea and Vomiting on Caesarean Section [NA]
A completed clinical trial evaluating intrathecal dexamethasone and atropine to prevent morphine-induced postoperative nausea and vomiting a…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Autonomic Neural Field Block for Visceral Pain in Minimally Invasive Left-Sided Colectomy
A clinical trial update describing a study of autonomic neural field block to manage visceral pain during minimally invasive left-sided cole…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Effect of Fresh Gas Flow Differences on Postoperative Nausea and Vomiting [NA]
Clinical trial update examining whether differences in fresh gas flow influence postoperative nausea and vomiting in patients undergoing sep…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Advancing Strategies to Optimize the PerIopeRativE Management of PostOperative Nausea and Vomiting (ASPIRE-PONV) Trial [NA]
The ASPIRE-PONV trial conducted by Vanderbilt University Medical Center is currently recruiting to optimize perioperative management of post…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Opioid Sparing Anesthesia Care for Pediatric Patients Having Tonsil Surgery [NA]
A pediatric trial at Boston Children's Hospital is recruiting to study opioid-sparing anesthesia strategies for children undergoing tonsil s…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Aromatherapy in Reducing PONV for Total Joint Replacement Patients [NA]
A clinical trial evaluating aromatherapy to reduce postoperative nausea and vomiting in patients undergoing total joint replacement; recruit…
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: Chewing Gum Flavors to Reduce Postoperative Nausea and Vomiting After PIPAC [NA]
Clinical trial update describing an ongoing study of chewing gum flavors to reduce postoperative nausea and vomiting after PIPAC in patients…
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: The Impact of Preoperative Olanzapine on Quality of Recovery After Discharge From Ambulatory Surgery [Phase 2]
This clinical trial update concerns a Phase 2 study from Yale University evaluating preoperative olanzapine for improving quality of recover…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Effects of taVNS Combined With Dexmedetomidine on POVN [NA]
A clinical trial evaluating transcutaneous auricular vagus nerve stimulation (taVNS) combined with dexmedetomidine for postoperative nausea …
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Intraoperative Acupoint Stimulation to Prevent Post-Operative Nausea and Vomiting (PONV) [NA]
This clinical trial update reports completion and results posting for a study evaluating intraoperative acupoint stimulation to prevent post…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Use of Transcutaneous Electrical Nerve Stimulation Device, Reletex Reliefband, With Current ERAS (Enhanced Recovery After Surgery) Protocol to Further Decrease Postoperative Nausea and Vomiting in the Bariatric Surgical Patient Within the First 24 Hours Postoperatively. [NA]
A clinical trial at the University of Pennsylvania is evaluating whether adding the Transcutaneous Electrical Nerve Stimulation device Relie…
-
FDA approval · 2025-11-24FDA Approved: ONDANSETRON — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for ondansetron from Rising Pharma Holdings, Inc., under the existing ANDA.
-
FDA approval · 2025-11-18FDA Approved: ONDANSETRON — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for ondansetron filed by Hospira, approving modifications to an already approved product under an AN…
-
FDA approval · 2025-11-18FDA Approved: ONDANSETRON — Supplemental Application (Hospira, Inc.)
FDA granted Hospira, Inc. a supplemental approval for ondansetron (ONDANSETRON) under an ANDA.
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: Outcome of Multimodal Anesthesia Bern [NA]
This clinical trial update reports the completed results of a multimodal anesthesia study conducted at Bern, focusing on opioid use, postope…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Dexamethasone Palmitate for PONV After Minimally Invasive Endoscopic Surgery [NA]
A clinical trial is evaluating dexamethasone palmitate to prevent postoperative nausea and vomiting after minimally invasive endoscopic surg…
-
FDA approval · 2025-11-17FDA Approved: ONDANSETRON — Supplemental Application (JVET PHARMACEUTICALS LLC)
FDA approved a supplemental application for ondansetron from JVET Pharmaceuticals LLC under an ANDA (generic). The approval covers the use o…
-
EMA approval · 2025-10-24EMA Authorised: Emend (aprepitant) — Merck Sharp & Dohme B.V.
The EMA authorised Emend (aprepitant) by Merck Sharp & Dohme B.V. for prevention of vomiting and nausea in cancer patients, including postop…